What´s new in high-resolution radionuclide imaging?

This technique is increasingly used to detect breast cancer and has been shown to improve diagnosis in many clinical situations. It is also allowing clinicians to detect previously unknown areas of breast cancer in women with newly diagnosed disease.

Radionuclide Bone Imaging
Radionuclide Bone Imaging

Involved in the technique’s development, Professor Rachel Brem, Director of the Breast Imaging and Interventional Centre and Professor of Radiology at George Washington University, Washington DC, explained: ‘High resolution nuclear medicine imaging of the breast is a functional approach to breast cancer diagnosis.

This uses a high resolution, breast specific gamma imaging that allows for the detection of both invasive and non-invasive breast cancer that are as small as 1mm. We can reliably detect 2mm cancers with this approach.’ 

The approach of breast specific gamma imaging (BSGI) is that, unlike mammography and ultrasound – based on anatomy and asking what breast cancer looks like - BSGI asks how breast cancer functions differently to the normal surrounding breast tissue.

22.02.2012

Related articles

Photo

News • Triple-negative breast cancer

Novel radiotracer identifies TNBC biomarker

A new PET tracer has the potential to play a critical role in the diagnosis, treatment, and monitoring of aggressive triple-negative breast cancer (TNBC), improving clinical outcomes for patients.

Photo

Article • Imaging in characterisation and classification of tumour types

Taking a closer look at breast cancer

Breast cancer has no “one size fits all” therapy approach: subtypes differ significantly in malignancy, progression, and treatment response. Therefore, the more is known about the type of…

Photo

News • New imaging agent

HER2-positive breast cancer: Whole-body PET/CT predicts targeted therapy response

A new imaging agent can predict early metabolic response to HER2-targeted treatment in metastatic breast cancer patients, according to new research published in the Journal of Nuclear Medicine.

Related products

Subscribe to Newsletter